Displaying 1 to 20 of 20 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ablation Frontiers Inc Medical device company that has developed and marketed cardiac ablation devices. |
United States | N/A Active |
||
|
|
Align Technology Inc |
United States | N/A Active |
||
|
|
Aptus Endosystems Inc |
United States | 1 Jun 2012 | Series B Active |
|
|
|
BaroNova Inc Developer of non-surgical devices to induce weight loss |
United States | 23 Nov 2015 | Series D Led the investment round. Active |
|
|
CardioDx Inc |
United States | 1 Aug 2012 | Series F Initial investment. Round participant. Active |
|
|
|
Codexis Inc Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. |
United States | N/A |
||
|
|
CryoVascular Systems Inc Medical device company for peripheral arterial disease. |
United States | N/A |
||
|
|
Embolic Protection Inc |
United States | N/A |
||
|
|
eyeonics Inc |
United States | N/A |
||
|
|
Eyetech Pharmaceuticals Inc Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. |
United States | N/A |
||
|
|
Insulet Corp |
United States | N/A |
||
|
|
MAP Pharmaceuticals Inc Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. |
United States | N/A |
||
|
|
ORATEC Interventions Inc |
United States | N/A |
||
|
|
PixelOptics Inc Develops, manufactures, and markets electronic spectacle lenses |
United States | 7 Apr 2011 | N/A |
|
|
|
Prestwick Pharmaceuticals Inc A specialty pharmaceutical company engaged in the development and marketing of drugs for diseases of the CNS. |
United States | N/A |
||
|
|
Sadra Medical Inc |
United States | N/A |
||
|
|
Sequenom Inc Biotechnology tools and diagnostics company. |
United States | N/A |
||
|
|
Sugen Inc Biopharmaceutical company that discovered and developed small molecule drugs used for diseases such as cancer and diabetes. |
United States | N/A |
||
|
|
Threshold Pharmaceuticals Inc |
United States | N/A |
||
|
Tricida Inc |
United Kingdom | 15 Jul 2016 | Series C Led the investment round. Active |